{"disease":{"id":"platysma-prominence","name":"platysma prominence"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04994535","title":"A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":426,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04949399","title":"A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":408,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05134649","title":"A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":292,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03915067","title":"BOTOX® for the Treatment of Platysma Prominence","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":171,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT05773053","title":"A Study of NT 201 Doses in the Treatment of Platysma Prominence","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Merz Aesthetics GmbH","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}